Integra LifeSciences Holdings (IART) — Free Cash Flow Generation Index
Integra LifeSciences Holdings (IART) has a Free Cash Flow Generation Index of 0.63x as of September 2025. Free cash flow of $25.75 Million represents 1% of operating cash flow ($40.91 Million). See Integra LifeSciences Holdings current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Integra LifeSciences Holdings Free Cash Flow Generation Index (1999–2024)
Historical FCF Generation Index trend for Integra LifeSciences Holdings across 25 annual periods. Explore IART cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Integra LifeSciences Holdings (1999–2024)
Year-by-year Free Cash Flow Generation Index for Integra LifeSciences Holdings. For the full company profile including market capitalisation, see IART market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.19x | $24.96 Million | $129.38 Million | $104.42 Million | ▼ -63.1% |
| 2023 | 0.52x | $73.09 Million | $139.96 Million | $66.86 Million | ▼ -36.5% |
| 2022 | 0.82x | $217.38 Million | $264.47 Million | $47.09 Million | ▼ -2.9% |
| 2021 | 0.85x | $264.35 Million | $312.43 Million | $48.08 Million | ▲ +23.2% |
| 2020 | 0.69x | $139.94 Million | $203.83 Million | $63.89 Million | ▲ +64.0% |
| 2019 | 0.42x | $96.90 Million | $231.43 Million | $134.53 Million | ▼ -31.4% |
| 2018 | 0.61x | $121.94 Million | $199.68 Million | $77.74 Million | ▼ -1.5% |
| 2017 | 0.62x | $71.04 Million | $114.54 Million | $43.50 Million | ▲ +4.5% |
| 2016 | 0.59x | $69.08 Million | $116.41 Million | $47.33 Million | ▼ -8.2% |
| 2015 | 0.65x | $61.07 Million | $94.48 Million | $33.41 Million | ▲ +38.6% |
| 2014 | 0.47x | $37.07 Million | $79.46 Million | $42.40 Million | ▲ +358.7% |
| 2013 | 0.10x | $5.42 Million | $53.27 Million | $47.85 Million | ▲ +157.9% |
| 2012 | -0.18x | $-10.32 Million | $58.72 Million | $69.03 Million | ▼ -127.8% |
| 2011 | 0.63x | $65.90 Million | $104.33 Million | $38.42 Million | ▼ -2.5% |
| 2010 | 0.65x | $68.43 Million | $105.57 Million | $37.14 Million | ▼ -19.7% |
| 2009 | 0.81x | $115.67 Million | $143.24 Million | $27.57 Million | ▼ -1.0% |
| 2008 | 0.82x | $59.19 Million | $72.59 Million | $13.40 Million | ▲ +56.8% |
| 2007 | 0.52x | $24.45 Million | $47.03 Million | $22.57 Million | ▼ -38.0% |
| 2006 | 0.84x | $60.18 Million | $71.70 Million | $11.52 Million | ▼ -2.2% |
| 2005 | 0.86x | $48.80 Million | $56.85 Million | $8.05 Million | ▲ +9.8% |
| 2004 | 0.78x | $30.47 Million | $38.98 Million | $8.51 Million | ▼ -12.1% |
| 2003 | 0.89x | $30.98 Million | $34.83 Million | $3.84 Million | ▼ -4.3% |
| 2002 | 0.93x | $29.73 Million | $31.98 Million | $2.25 Million | ▲ +13.7% |
| 2001 | 0.82x | $12.84 Million | $15.70 Million | $2.86 Million | ▲ +113.8% |
| 1999 | -5.92x | $-14.80 Million | $2.50 Million | $17.30 Million | — |